O96013 (PAK4_HUMAN) Homo sapiens (Human)

Serine/threonine-protein kinase PAK 4 UniProtKBInterProSTRINGInteractive Modelling

591 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
CDC42 binds PAK4 via an extended GTPase-effector interface - 3 peptide: PAK4cat, PAK4-N45, CDC42 Heteromer
P60953;
4-588
100ANP;GNP;MG;
Catalytic domain of human PAK4 with RPKPLVDP peptide Heteromer
49-590
100
Catalytic domain of human PAK4 with RPKPLVDP peptide Heteromer
49-589
100ANP;
In vitro Crystal Structure of PAK4 in complex with Inka peptide Heteromer
Q96EL1;
297-589
100
PAK4 kinase domain in complex with LIMK1 Thr508 substrate peptide Heteromer
P53667;
299-590
100
PAK4 kinase domain in complex with beta-catenin Ser675 substrate peptide Heteromer
P35222;
299-590
100
CDC42 binds PAK4 via an extended GTPase-effector inteface - 2 peptide: PAK4FL, CDC42 - UNREFINED Heteromer
P60953;
299-589
100
PAK4cat in complex with Integrin beta5 760-770 peptide Heteromer
P18084;
300-589
100
Integrin beta5(743-774)-linker-PAK4cat(D440N/S474E) Heteromer
P18084;
300-589
99.31ANP;
PAK4cat (D440N/S474E) in complex with Integrin beta5 760-770 peptide Heteromer
P18084;
300-589
99.31ANP;
The crystal structure of the human RAC3 in complex with the CRIB domain of human p21-activated kina… Heteromer
P60763;
10-43
100MG;CL;GCP;
Full-length human PAK4monomer49-590
100.0ANP;
In cellulo Crystal Structure of PAK4 in complex with Inkamonomer278-589
100.0ATP;MG;
Structure of human p21 activating kinase 4 (PAK4) in complex with a consensus peptidemonomer298-591
100SO4;EDO;
The Crystal Structure of P21-Activated Kinases Pak4 from Biortusmonomer298-591
100PGE;
Catalytic domain of human PAK4monomer298-590
100ANP;MG;
Crystal Structure of PAK4 in complex with inhibitor CZg353monomer300-591
1009EO;EDO;TRS;BCT;
Crystal Structure of PAK4 in complex with inhibitor CZH216monomer300-591
1008FU;EOH;
PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discoverymonomer300-591
99.66M4I;
Catalytic domain of human PAK4 with QKFTGLPRQW peptidemonomer298-589
100
PAC FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discoverymonomer300-591
99.66M4X;
Crystal Structure of PAK4 in complex with inhibitor CZH226monomer300-591
1008FX;EOH;EDO;
Crystal Structure of the Human p21-Activated Kinase 4 in Complex with PF-03758309monomer299-590
99.66GOL;7KC;
Crystal Structure of the Human p21-Activated Kinase 4 in Complex with (S)-N-(5-(3-benzyl-1-methylpi…monomer300-591
100N53;GOL;
Catalytic domain of human PAK4monomer299-590
100
CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514Amonomer299-590
100.023D;SO4;CL;
Crystal Structure of PAK4 in complex with inhibitor 55monomer300-591
100GCC;
PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discoverymonomer300-591
99.66M56;
CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4monomer300-589
100EDO;
PAK4 kinase domain in complex with fasudilmonomer300-589
100M77;ACT;
Crystal structure of Serine/threonine-protein kinase PAK 4 in complex with Paktide S peptide substr…monomer300-589
100ANP;MG;
Crystal structure of Serine/threonine-protein kinase PAK 4 in complex with Paktide T peptide substr…monomer300-589
100
Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitorsmonomer300-589
1002OO;
Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide T p…monomer300-589
99.66
PAK4 kinase domain in complex with Staurosporinemonomer300-589
100STU;
Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S p…monomer300-589
99.66
Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitorsmonomer300-589
1002OQ;
PAK4 kinase domain in complex with FRAX486monomer300-589
100981;
Structure of p21-activated kinase 4 with a novel inhibitor KY-04031monomer300-589
100NJD;
Crystal Structure of PAK4 in complex with inhibitor 41monomer300-589
100G5X;
Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitorsmonomer300-589
1002OL;
Crystal Structure of Catalytic Domain of PAK4monomer300-589
100
Crystal Structure of PAK4 in complex with inhibitor 47monomer300-589
100GC6;
Crystal structure of P21-activated kinase 4 in complex with an inhibitor compound 29monomer300-589
1004T6;
Crystal Structure of PAK4 in complex with inhibitor CZH062monomer300-588
1008FR;
Structure of PAK4monomer301-589
10067U;
Crystal structure of the human P21-activated kinase 4monomer300-587
100.0

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4fie.1.Amonomer0.6449-590
ANP;98.58

3 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24fie.1.Amonomer0.7849-425
ANP;100.00
Isoform 34fie.1.Amonomer0.7549-437
ANP;89.10
Isoform 44fie.1.Amonomer0.7149-500
ANP;99.76